15.07.2020 - REFINE Project: Survey
Anticipation of regulatory needs for nanotechnology-enabled health products.
Launched in December 2017, H2020 project REFINE aims to develop a regulatory science framework for nanotechnology-enabled health products.
Recently released REFINE’s White Paper summarises main regulatory challenges in the field and provides information on relevant legislative/regulatory frameworks and involved organisations.
The REFINE White Paper and related scientific publication “Launching stakeholder discussions on identified regulatory needs for nanotechnology-enabled health products” call for a discussion on identified challenges among the involved communities, including regulators, industry and academia.
In order to better understand the needs and perspectives of different communities, a short questionnaire is available HERE. The feedback should help to develop an improved version of the White Paper.
The REFINE Project Team